Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2results about How to "Cytotoxic" patented technology

Novel compounds derived from myristic acid and anticancer compositions comprising the same

PendingCN122094928Acytotoxicstrong cytotoxicityOrganic chemistry methodsKetone active ingredientsCancer cellNutmeg extract
This invention relates to a novel compound derived from nutmeg and an anticancer composition comprising the same. The present invention isolates several novel compounds derived from nutmeg extract and confirms that most of these novel compounds exhibit cytotoxic activity against various cancer cell lines. Five compounds (3, 4, 6, 9, and 11) were identified as having high cytotoxic activity against gastric and colorectal cancers. In particular, the compound represented by chemical formula 3 was confirmed to not only effectively induce apoptosis by regulating the cell cycle of cancer cells but also effectively inhibit tumor growth in xenograft mouse models, thus making it an effective anticancer composition.
Owner:KOREA INST OF SCI & TECH

Bovine-derived A-type pasteurella multocida PM1790 protein and Pm1790 gene and application thereof

The invention discloses a bovine-derived A-type pasteurella multocida PM1790 protein, a Pm1790 gene and application of the bovine-derived A-type pasteurella multocida PM1790 protein and the Pm1790 gene, and relates to the technical field of biological products, and the amino acid sequence of the bovine-derived A-type pasteurella multocida PM1790 protein is as shown in SEQ ID NO. 1. The invention also discloses a bovine-derived A-type pasteurella multocida Pm1790 gene which is used for coding a bovine-derived A-type pasteurella multocida PM1790 protein, and the nucleotide sequence of the bovine-derived A-type pasteurella multocida Pm1790 gene is as shown in SEQ ID NO. 2. The invention also discloses an application of the bovine-derived type A pasteurella multocida PM1790 protein or the Pm1790 gene in preparation of a pasteurella multocida vaccine. The vaccine prepared from the strain lacking the Pm1790 gene can induce the generation of a high-level antibody, and can effectively prevent the infection of pasteurella multocida of various strain types.
Owner:SOUTHWEST UNIV